Neil Berkley

Neil Berkley

Director of Finance/CFO at ALECTOR, INC.

Net worth: 820 584 $ as of 31/05/2026

53 year
Health Technology
Consumer Services
Commercial Services

Profile

Neil L.
Berkley
is the founder of MPEX Pharmaceuticals, Inc., founded in 2001, and Vaxiion Therapeutics LLC, founded in 2000.
Mr. Berkley is currently Director at Navigen, Inc. and will be Chief Financial & Business Officer at Alector, Inc. starting in 2025.
Former jobs include Independent Non-Executive Director at ProLung, Inc. in 2018; Chief Business Officer at AbCellera Biologics, Inc. from 2021 to 2022; Vice President & Head-Business Development at Halozyme Therapeutics, Inc. from 2019 to 2021; Chief Corporate Development Officer at Juvena Therapeutics, Inc. from 2022 to 2024; and Head-Business Development at Cadence Pharmaceuticals, Inc. from 2011 to 2014.
Education includes graduate and MBAistration degrees from San Diego State University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
02/06/2026 379,900 ( 0.34% ) 820 584 $ 31/05/2026

Neil Berkley active positions

CompaniesPositionStart
ALECTOR, INC. Director of Finance/CFO 20/06/2025
Director/Board Member -

Former positions of Neil Berkley

CompaniesPositionEnd
Corporate Officer/Principal 01/04/2024
ABCELLERA BIOLOGICS INC. Corporate Officer/Principal 29/06/2022
HALOZYME THERAPEUTICS, INC. Corporate Officer/Principal 01/07/2021
PROLUNG, INC. Director/Board Member 27/06/2018
Cadence Pharmaceuticals , Inc.
Corporate Officer/Principal 01/05/2014
See the detail of Neil Berkley's experience

Training of Neil Berkley

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

15

1st degree connections

11

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies11

Health Technology

Health Technology

Consumer Services

Consumer Services

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Cadence Pharmaceuticals , Inc.

Health Technology

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!